OSE Immunotherapeutics Unveils 2026–2028 Strategic Plan With Four Opportunities for Value Creation Completion of Tedopi’s phase 3 in Non-Small Cell Lung Cancer One or two new rare/specialty ...

Potential state revenues in 2026 from Indonesia's planned gold export tax could reach 3 trillion rupiah ($179.75 million) ...

Centurion entrepreneur Koketso Ramatlho has won more than R250 000 on Engen The Making Of 2025, securing new funding to ...

New Delhi: The initial public offering (IPO) of pharma firm Corona Remedies, received 62 per cent on the first day of the ...

Ocular intends to submit AXPAXLI New Drug Application (NDA) for wet AMD shortly after year one data from SOL-1, if positive ...

The year's biggest health story by far has been the cuts to US aid for health and US support for health research. But it's also been a year of important HIV prevention developments, NHI court cases, ...

A journey of relentless commitment, Komal Ganotra bridges grassroots activism and policy reform to safeguard children and ...

China will continue exerting a "more proactive" fiscal policy and "moderately loose" monetary policy next year, as it strives ...

When referring to this article, please cite it as Hennessy, M. How Innovation and Risk Management Are Reshaping Modern Drug ...

David L. Holmberg, chief executive officer for Highmark Health and chairman of the board, Highmark Inc., has again been ...

Over 1,000 industry leaders to converge in Bhubaneswar for Odisha Pharma Summit on December 16: Peethaambaran Kunnathoor, Chennai Tuesday, December 9, 2025, 08:00 Hrs [IST] The mu ...

Medley is a global pharmaceutical company operating since 1969 from Mumbai, India. Medley launches Biscal D, a calcium and ...